SR

Sanket Ramesh Ghumare

Active Director Director DIN 10123903
DIN 10123903 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanket Ramesh Ghumare

Data last updated:

Sanket Ramesh Ghumare is a Director at Cure Lines Medicare Private Limited (since 2023). The company operates in Paper.

DIN 10123903
Primary Designation Director
Industry Paper
First Appointment 19 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cure Lines Medicare Private Limited U21001PN2023PTC219722
Director19 Apr 20232023Active

Board colleagues of Sanket Ramesh Ghumare

NameDINCompanyDesignation
Aishwarya Raju Bhagwat10123902Cure Lines Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cure Lines Medicare Private Limited
Premium access

Shareholding and investment profile for Sanket Ramesh Ghumare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanket Ramesh Ghumare

Sanket Ramesh Ghumare currently holds 1 directorship: Cure Lines Medicare Private Limited (Director, since 19 Apr 2023).

Sanket Ramesh Ghumare was first appointed on 19 Apr 2023 as Director at Cure Lines Medicare Private Limited.

The current boards of Sanket Ramesh Ghumare's companies include Aishwarya Raju Bhagwat (Cure Lines Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available